- Previous Close
242.62 - Open
239.04 - Bid --
- Ask 255.00 x 800
- Day's Range
229.94 - 240.18 - 52 Week Range
164.12 - 260.49 - Volume
868,392 - Avg. Volume
931,491 - Market Cap (intraday)
33.794B - Beta (5Y Monthly) 0.69
- PE Ratio (TTM)
30.49 - EPS (TTM)
7.55 - Earnings Date Jan 22, 2025 - Jan 27, 2025
- Forward Dividend & Yield 2.12 (0.92%)
- Ex-Dividend Date Nov 7, 2024
- 1y Target Est
253.11
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
www.resmed.comRecent News: RMD
View MorePerformance Overview: RMD
Trailing total returns as of 12/18/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: RMD
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: RMD
View MoreValuation Measures
Market Cap
33.79B
Enterprise Value
34.22B
Trailing P/E
30.53
Forward P/E
25.19
PEG Ratio (5yr expected)
1.75
Price/Sales (ttm)
7.07
Price/Book (mrq)
6.51
Enterprise Value/Revenue
7.12
Enterprise Value/EBITDA
21.05
Financial Highlights
Profitability and Income Statement
Profit Margin
23.15%
Return on Assets (ttm)
13.27%
Return on Equity (ttm)
23.57%
Revenue (ttm)
4.81B
Net Income Avi to Common (ttm)
1.11B
Diluted EPS (ttm)
7.55
Balance Sheet and Cash Flow
Total Cash (mrq)
442.58M
Total Debt/Equity (mrq)
16.37%
Levered Free Cash Flow (ttm)
1.12B